Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6412981rdf:typepubmed:Citationlld:pubmed
pubmed-article:6412981lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:6412981lifeskim:mentionsumls-concept:C0014792lld:lifeskim
pubmed-article:6412981lifeskim:mentionsumls-concept:C0005804lld:lifeskim
pubmed-article:6412981lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:6412981lifeskim:mentionsumls-concept:C1704241lld:lifeskim
pubmed-article:6412981pubmed:issue15lld:pubmed
pubmed-article:6412981pubmed:dateCreated1983-11-23lld:pubmed
pubmed-article:6412981pubmed:abstractText19 antibodies specific for 11 different drugs were extensively tested in the presence of the drug against a panel of red cells including common and public minus phenotypes. High incidence blood group antigens were shown to be specific receptors for several drug-antibody complexes proving thereby that red blood cells play more than an "innocent bystander" role in drug induced immune hemolytic anemias.lld:pubmed
pubmed-article:6412981pubmed:languagefrelld:pubmed
pubmed-article:6412981pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6412981pubmed:citationSubsetIMlld:pubmed
pubmed-article:6412981pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6412981pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6412981pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6412981pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6412981pubmed:statusMEDLINElld:pubmed
pubmed-article:6412981pubmed:issn0249-6313lld:pubmed
pubmed-article:6412981pubmed:authorpubmed-author:HabibiBBlld:pubmed
pubmed-article:6412981pubmed:authorpubmed-author:BretagneYYlld:pubmed
pubmed-article:6412981pubmed:issnTypePrintlld:pubmed
pubmed-article:6412981pubmed:volume296lld:pubmed
pubmed-article:6412981pubmed:ownerNLMlld:pubmed
pubmed-article:6412981pubmed:authorsCompleteYlld:pubmed
pubmed-article:6412981pubmed:pagination693-6lld:pubmed
pubmed-article:6412981pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:6412981pubmed:meshHeadingpubmed-meshheading:6412981-...lld:pubmed
pubmed-article:6412981pubmed:meshHeadingpubmed-meshheading:6412981-...lld:pubmed
pubmed-article:6412981pubmed:meshHeadingpubmed-meshheading:6412981-...lld:pubmed
pubmed-article:6412981pubmed:meshHeadingpubmed-meshheading:6412981-...lld:pubmed
pubmed-article:6412981pubmed:meshHeadingpubmed-meshheading:6412981-...lld:pubmed
pubmed-article:6412981pubmed:meshHeadingpubmed-meshheading:6412981-...lld:pubmed
pubmed-article:6412981pubmed:meshHeadingpubmed-meshheading:6412981-...lld:pubmed
pubmed-article:6412981pubmed:meshHeadingpubmed-meshheading:6412981-...lld:pubmed
pubmed-article:6412981pubmed:meshHeadingpubmed-meshheading:6412981-...lld:pubmed
pubmed-article:6412981pubmed:year1983lld:pubmed
pubmed-article:6412981pubmed:articleTitle[Blood group antigens may be the receptors for immunoallergic drug complexes reacting with erythrocytes].lld:pubmed
pubmed-article:6412981pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6412981pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:6412981pubmed:publicationTypeEnglish Abstractlld:pubmed